Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials

British Medical Journal

Volumn 326, Issue 7404, 2003, Pages 1427-1431

  Law, M R ^a   Wald, N J ^a   Morris, J K ^a   Jordan, R E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; THIAZIDE DIURETIC AGENT;

ARTICLE; CLINICAL TRIAL; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; META ANALYSIS; METABOLIC DISORDER; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; STROKE; SYMPTOM; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0037490085     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
2. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003;21:707-16.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
5. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
6. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny BMJ 2002;324:1570-6.
7. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and strokes: a new preventive strategy. Health Technol Assess 2003; in press.
8. Seedat YK. Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens 1989;7:515-8.
9. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary: September 2001. London: BMJ Books, 2001.
10. Reynolds JEF, ed. Martindale: the extra pharmacopoeia. London: Royal Pharmaceutical Society, 1996.
11. Monthly Index of Medical Specialties (MIMS): August 2001. London: Haymarket Medical, 2001.
12. Coulter DM, Edwards IR. Cough associated with captopril and enalapril. BMJ 1987;294:1521-3.
13. Israili ZH, Dallas Hall Z. Cough and angioneurotic edema associates with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992;117:234-42.
14. Grimm RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Hypertension 1997;29:8-14.
15. Freis ED. Critique of the clinical importance of diuretic-induced hypokalemia and elevated cholesterol level. Arch Intern Med 1989;149:2640-8.
16. Kaplan NM, Carnegie A, Raskin P, Heller JA, Simmons M. Potassium supplementation in hypertensive patients wild diuretic-induced hypokalemia. N Engl J Med 1985;312:746-9.
17. Papademetriou V, Price M, Johnson E, Smith M, Freis ED. Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol 1984;54:1015-9.
18. Wilkinson PR, Issler H, Hesp R, Raftery EB. Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet 1975;1:759-62.
19. Papademetriou V, Burris JF, Notargiacomo A, Fletcher RD, Freis ED. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Arch Intern Med 1988;148:1272-6.
20. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 2000;342:905-12.
21. Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT. Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up. Lancet 1982;2:1293-5.
22. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the normative aging study. Am J Med 1987;82:421-6.
23. Greenberg G, Brennan PJ, Miall WE. Effects of diuretic and beta-blocker therapy in the Medical Research Council trial. Am J Med 1984;76(2A):45-51.